Joel Baublits, MS, brings extensive expertise in biostatistics and multimodal data analysis, specializing in cardiovascular, respiratory, and toxicology data interpretation. With a focus on integrating complex datasets from physiological monitoring systems, Joel ensures precise, statistically sound insights for regulatory submissions and product development. As co-founder of Cardiovascular Analytics, he collaborates with Ray Chui to provide comprehensive data analysis services that support preclinical study designs, safety pharmacology, and toxicological evaluations.

• Biostatistics & Multimodal Data Analysis:
  Proficient in applying advanced statistical methods to cardiovascular, respiratory, and toxicology datasets. Skilled in integrating data from multiple sources to ensure accurate analysis of physiological parameters.
• Cardiovascular, Respiratory & Toxicology Data Interpretation:
  Specializes in analyzing cardiovascular and respiratory data, including toxicological outcomes, providing detailed insights into study endpoints. Supports safety pharmacology and both acute and chronic toxicity studies with robust data interpretations.
• Statistical Software Expertise:
  Extensive experience with statistical platforms like SAS, R, Prism, and custom software solutions, ensuring seamless integration of multimodal datasets and generation of comprehensive, regulatory-compliant reports.
• GLP Compliance & Quality Control:
  Validated systems and software, in accordance with Nonclinical Laboratory Studies Good Laboratory Practice (GLP) regulations issued by the US Food and Drug Administration (FDA, Title 21, Part 58).
• Diligent, Comprehensive, & Timely Reporting:
  Delivers high-quality reports that meet regulatory standards, with a focus on rapid turnaround times and accuracy. Provides clients with clear, actionable data to meet tight deadlines without sacrificing detail.
• Preclinical Study Design & Reporting:
  Experienced Study Director/Principal Investigator that plays a crucial role in designing and analyzing preclinical studies, ensuring that all protocols meet regulatory requirements. Supports study accuracy and reliability through statistical rigor in cardiovascular, respiratory, and toxicology fields.

Joel is driven by a passion for transforming complex datasets into meaningful, actionable insights. With a natural affinity for biostatistics and multimodal data analysis, he approaches each project with a keen eye for precision and a commitment to producing results that support both innovation and regulatory standards. Joel’s philosophy centers around working collaboratively with clients to create clear, impactful reporting that enables better decision-making, ultimately leading to improved patient care. As co-leader of Cardiovascular Analytics with Ray, Joel values the partnership they’ve cultivated, ensuring that each project is approached with care, professionalism, and a client-focused mentality.

Data Analysis
Report Generation
Regulatory
Training
Biostatistics

DSI Ponemah
EMKA ecgAUTO
SAS
R
Prism